A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Efficacy of Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg in a Continuous Daily Regimen for Oral Contraception
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Ethinylestradiol/levonorgestrel (Primary)
- Indications Pregnancy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Wyeth
- 13 Feb 2013 New trial record